T2 Biosystems (FRA:3T2) EV-to-Revenue : 3.74 (As of Dec. 11, 2024)

View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, T2 Biosystems's enterprise value is €26.35 Mil. T2 Biosystems's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €7.04 Mil. Therefore, T2 Biosystems's EV-to-Revenue for today is 3.74.

The historical rank and industry rank for T2 Biosystems's EV-to-Revenue or its related term are showing as below:

FRA:3T2' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.4 Med: 13.69 Max: 3305.03
Current: 3.62

During the past 12 years, the highest EV-to-Revenue of T2 Biosystems was 3305.03. The lowest was 1.40. And the median was 13.69.

FRA:3T2's EV-to-Revenue is ranked worse than
56.94% of 216 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.11 vs FRA:3T2: 3.62

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-11), T2 Biosystems's stock price is €0.532. T2 Biosystems's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €0.98. Therefore, T2 Biosystems's PS Ratio for today is 0.54.

T2 Biosystems EV-to-Revenue Historical Data

The historical data trend for T2 Biosystems's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems EV-to-Revenue Chart

T2 Biosystems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

11.40

10.94

3.99

2.68

8.24

T2 Biosystems Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-Revenue	Get a 7-Day Free Trial															10.16	8.24	8.34	15.06	7.01

Competitive Comparison of T2 Biosystems's EV-to-Revenue

For the Diagnostics & Research subindustry, T2 Biosystems's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

T2 Biosystems's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's EV-to-Revenue falls into.

T2 Biosystems EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

T2 Biosystems's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	26.349	/	7.037
	=	3.74

T2 Biosystems's current Enterprise Value is €26.35 Mil.
T2 Biosystems's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €7.04 Mil.

T2 Biosystems (FRA:3T2) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

T2 Biosystems's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.532	/	0.98
	=	0.54

T2 Biosystems's share price for today is €0.532.
T2 Biosystems's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.98.

T2 Biosystems EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

T2 Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

TTOO:USA 0A57:UK 3T2:Germany

Address

101 Hartwell Avenue, Lexington, MA, USA, 02421

Website

https://www.t2biosystems.com

T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

T2 Biosystems Headlines

No Headlines